| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5824481 | Clinical Therapeutics | 2016 | 13 Pages | 
Abstract
												Delafloxacin was well tolerated in healthy volunteers after single and multiple IV doses. The total systemic exposure to IV (300 mg) and oral (450 mg) delafloxacin is comparable, supporting that a switch between the 2 formulations is appropriate.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Medicine and Dentistry (General)
												
											Authors
												Randall PhD, Thomas MD, Michael BS, Susan K. PhD, Laura BS, Sue MD, Eugene MD, 
											